🇬🇧 Michael (UK) — ordered Rafinlar 50mg Capsule 28's · 14 min ago
🇨🇦 Priya (Canada) — bulk enquiry · 38 min ago
🇦🇺 Order shipped to Melbourne — DHL Express tracked
🇫🇷 Laurent (France) — 4th repeat order confirmed ✓
🇸🇬 Bulk supply to Singapore clinic — 40 units confirmed
🇩🇪 Klaus (Germany) — enquiry for Rafinlar 50mg Capsule 28's
🇺🇸 Dr. Chen (USA) — hospital order confirmed
🇦🇪 Ahmad (UAE) — 5★ verified buyer
🇳🇱 Order to Netherlands · discreet pack
🇯🇵 Kenji (Japan) — export docs requested
🇬🇧 Michael (UK) — ordered Rafinlar 50mg Capsule 28's · 14 min ago
🇨🇦 Priya (Canada) — bulk enquiry · 38 min ago
🇦🇺 Order shipped to Melbourne — DHL Express tracked
🇫🇷 Laurent (France) — 4th repeat order confirmed ✓
🇸🇬 Bulk supply to Singapore clinic — 40 units confirmed
🇩🇪 Klaus (Germany) — enquiry for Rafinlar 50mg Capsule 28's
🇺🇸 Dr. Chen (USA) — hospital order confirmed
🇦🇪 Ahmad (UAE) — 5★ verified buyer
🇳🇱 Order to Netherlands · discreet pack
🇯🇵 Kenji (Japan) — export docs requested

Rafinlar 50mg Capsule 28’s

Manufactured by / Trademark:
80 viewing now
18 enquiries / 48 hrs
9 shipped / week
PA
NI
JI
3 verified buyers rated 5★
4.7★
Reference Price
$29,998
Final price confirmed on enquiry
In Stock — Ships within 48 hrs
📦 Bulk discounts available — enquire for volume pricing
3 reviews
Genuine Stock
📋
Export Docs
📦
Discreet Pack
🌡️
Cold-Chain
🚚 Estimated Delivery to Your Country
🇬🇧🇩🇪🇫🇷
Europe
7–10 days
Express courier
🇺🇸🇨🇦🇦🇺
US / CA / AU
10–14 days
EMS / courier
🇦🇪🇸🇦🇯🇵
Middle East / Asia
5–8 days
Express courier
Trustpilot
Excellent 4.6 / 5 21 verified reviews
🔒 Secure Payment Options
PayPal ₮ USDT 🏦 Wire / SWIFT
SSL encrypted · All transactions are private & secure

Q & A

Ask a question
There are no questions yet
Rafinlar 50mg Capsule (Dabrafenib) is a targeted cancer therapy used for melanoma patients with BRAF mutations, effectively inhibiting tumor growth and aiding in cancer management.
Rafinlar 50mg Capsule contains the active ingredient dabrafenib, a kinase inhibitor used in the treatment of specific cancers, including melanoma (a type of skin cancer) and non-small cell lung cancer (NSCLC) with BRAF V600 mutations. Dabrafenib works by inhibiting the activity of the mutated BRAF protein that promotes cancer cell growth. This targeted approach helps slow or stop the progression of cancer and is often used alone or in combination with other medications, such as trametinib, to enhance treatment effectiveness. Uses:
  • Treatment of unresectable or metastatic melanoma with BRAF V600 mutations.
  • Part of combination therapy for BRAF-mutated non-small cell lung cancer (NSCLC).
  • Used in specific cases of BRAF-mutated anaplastic thyroid cancer.
Side Effects:
  • Common side effects: headache, fever, fatigue, nausea, rash, and joint pain.
  • Serious side effects: risk of new cancers, bleeding problems, heart issues (e.g., heart failure or irregular heartbeat), eye issues (including vision changes), and severe skin reactions. Seek immediate medical attention for any severe or unexpected symptoms.
Key Features:
  • Contains dabrafenib, targeting BRAF V600-mutant cancers.
  • Inhibits tumor growth by blocking cancer-promoting protein activity.
  • Effective as monotherapy or in combination with other drugs, such as trametinib.
  • Designed for metastatic melanoma, lung cancer, and specific thyroid cancers with BRAF mutations.
FAQ:
  1. How does Rafinlar 50mg Capsule work? Rafinlar inhibits the activity of the mutated BRAF protein, which is responsible for driving cancer cell growth, thus slowing or stopping tumor progression in cancers with this mutation.
  2. Who can use Rafinlar? It is prescribed for patients whose cancers have the BRAF V600 mutation, such as metastatic melanoma or specific lung and thyroid cancers, as confirmed by genetic testing.
  3. What precautions should I take while using Rafinlar? Close monitoring is required to manage potential side effects like heart issues or skin reactions. Inform your healthcare provider of any underlying conditions and take precautions against sun exposure due to increased risk of skin reactions.
References:
  1. Novartis Pharmaceuticals Corporation. “Rafinlar (dabrafenib) Capsules.” [Accessed on 5 Nov 2024]. Available from: https://en.wikipedia.org/wiki/Dabrafenib
  2. European Medicines Agency (EMA). “Dabrafenib Product Information.” [Accessed on 5 Nov 2024]. Available from: https://www.cancer.gov/news-events/cancer-currents-blog/2022/fda-dabrafenib-trametinib-braf-solid-tumors
🟢 Recent Orders
🇬🇧
David — United Kingdom
2 hours ago
Shipped ✓
🇦🇪
Ahmad — UAE
5 hours ago
Confirmed ✓
🇫🇷
Thomas — France
Yesterday
3rd order ✓
🇨🇦
Sarah — Canada
2 days ago
Bulk order ✓